In support of increasing living donation, especially living kidney donation for people with kidney failure, ASN applauds today’s reintroduction of the Living Donor Protection Act of 2021 by Representatives Jerry Nadler (D-NY) and Jaime Herrera-Beulter (R-WA), and Senators Kristen Gillibrand (D-NY) and Tom Cotton (R-AR).
The next 10 years have been dubbed the "decade of the kidney." To realize this promise, we must improve care, expand research, and bolster education by 2030. The first step is recognizing the urgent need to translate innovation into reality for the more than 850 million people worldwide with kidney diseases, kidney failure, and kidney transplants.
"Michelle was an incredible physician scientist and human being. She was the heart and soul of our podocyte community. To me, she was the perfect role model, and exemplified everything that is good in medicine and the world. I feel privileged to have counted her as a colleague, a confidante and most of all, my friend. Her passing left many of us heartbroken. To her tribute, her legacy lives on in her many groundbreaking discoveries and amazing nephrologists like Dr. Gentzon." --Susan E. Quaggin, MD, FASN, President, American Society of Nephrology
More than 37,000,000 Americans are affected by kidney diseases, and inequities and disparities have long plagued the care for many of those affected. In a series of key recommendations to the Biden Administration, ASN pledged its support to address the twin public health crises of COVID-19 and systemic racism.
The American Society of Nephrology (ASN) strongly condemns the rise in hate crimes against Asian Americans throughout the United States. During the past year, more than 3,500 accounts of such incidents were reported, and ASN is committed to doing everything possible to prevent these injustices.
The long push for payment models to cross the silos of kidney care – chronic kidney disease (CKD), kidney failure and dialysis, and kidney transplant – continues with newly announced modifications to the implementation timeline of the Kidney Care Choices (KCC) Model, often referred to as the voluntary model. The Center for Medicare and Medicaid Innovation (CMMI), which creates models and created the ESCOs, has extended the implementation period from March 31, 2021, until December 31, 2021. The effective performance year that was scheduled to begin April 1, 2021 will now begin January 1, 2022.
The American Society of Nephrology (ASN) is spearheading efforts to secure direct federal allocation of COVID-19 vaccines to dialysis patients and frontline dialysis workers. This allocation would improve access for a vulnerable patient population, more than half of whom are Black, Hispanic, Asian, Native American, and Native Hawaiian or other Pacific Islanders (NHPIs).
Every member of the ASN Alliance for Kidney Health is excited to help elevate care, drive breakthroughs and innovation, educate and inform, and propel policies that create momentous changes in kidney health. To accomplish these goals and others, ASN and the rest of the alliance will:
1. Launch the ASN Health Justice Committee to address health disparities and influence social determinants of health in populations at risk for and overburdened with kidney diseases.
Approximately 50 percent of dialysis patients in the United States are Black, Latinx, Native American, or Native Hawaiian or other Pacific Islanders (NHPIs). These individuals are underrepresented in COVID-19 vaccination rates.1 In Virginia, for instance, Black people represent 19% of residents while accounting for 21% of the state’s COVID-19 cases and 24% of its deaths; however, Black Virginians have received only 12% of vaccines administered in the state to date.2